Case description
This article presents a single-centre experience with the first 33 consecutive patients (N=35 tumours) who underwent BCS showing that Sirius Pintuition is a feasible alternative to WGL and favourably reviewed by both surgeons and radiologists
Key messages
- 100% Pintuition markers were detected transcutaneously
- No SAEs recorded
- One large lesion was bracketed
- 97% Pintuition markers retrieved (one marker displaced during surgery but recovered and sent with the specimen)
- Favourably reviewed by both surgeons and radiologists
